Know Cancer

or
forgot password

    • cancer clinical trials in raleigh, NC

    • Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
    Associated Urologists of North Carolina
    Raleigh, North Carolina 27607
    Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
    Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
    Wake Research Associates

    Trial Locations
    Wake Research Associates
    PMG Research of Raleigh
    WakeMed Faculty Physicians Raleigh Cardiology
    Obesity, Overweight
    Belimumab Assessment of Safety in SLE
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Systemic Lupus Erythematosus
    Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis
    Shanahan Rheum & Immunology Pllc
    Raleigh, North Carolina 27617
    Lupus Nephritis
    Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T
    Raleigh Hematology Oncology Associates D.B.A., Cancer Centers of North Carolina
    Raleigh, North Carolina 27614
    Prostate Cancer
    Armodafinil in Reducing Cancer-Related Fatigue in Patients With Glioblastoma Multiforme
    Cancer Centers of North Carolina
    Raleigh, North Carolina 27607
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Fatigue
    A Twelve Week Safety and Efficacy Study in Rosacea
    Wake Resarch
    Raleigh, North Carolina 27612
    Papulopustular Rosacea
    A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months
    Central Prison/Women's Prison in Raleigh / NC
    Raleigh, North Carolina 276260540
    HIV Infections
    A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients
    Central Prison/Women's Prison in Raleigh / NC
    Raleigh, North Carolina 276260540
    HIV Infections
    Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer
    Rex Healthcare
    Raleigh, North Carolina 27607
    Breast Cancer, Metastatic Cancer, Pain, Prostate Cancer
    Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
    Raleigh Internal Medicine
    Raleigh, North Carolina 27609
    Hypercalcemia of Malignancy, Lung Cancer, Metastatic Cancer, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Raleigh Hematology/Oncology Associates, P.A. - Rex Cancer Center
    Raleigh, North Carolina 27607
    Breast Cancer
    Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer
    Raleigh Hematology/Oncology Associates - Wake Practice
    Raleigh, North Carolina 27609
    Colorectal Cancer
    Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer
    Raleigh Hematology/Oncology Associates - Wake Practice
    Raleigh, North Carolina 27609
    Pancreatic Cancer
    Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss
    Rex Healthcare
    Raleigh, North Carolina 27607
    Cachexia, Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
    Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung Cancer
    Raleigh Hematology/Oncology Associates - Wake Practice
    Raleigh, North Carolina 27609
    Lung Cancer
    Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Rex Healthcare
    Raleigh, North Carolina 27607
    Head and Neck Cancer, Oral Complications, Radiation Toxicity
    Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
    Raleigh Hematology/Oncology Associates - Wake Practice
    Raleigh, North Carolina 27609
    Colorectal Cancer
    The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC)
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Lung Cancer, Small Cell, Small Cell Lung Cancer
    GW572016, An Oral Drug For Women With Refractory Metastatic Breast Cancer After First-line Or Second-line Herceptin
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Metastatic Breast Cancer
    STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea
    Raleigh Hematology Oncology Associates, Wake Practice
    Raleigh, North Carolina 27609
    Neoplasms, Diarrhea
    Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Metastatic Breast Cancer, Neoplasms, Breast
    Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Peritoneal Cancer, Ovarian Cancer, Neoplasms, Ovarian, Fallopian Tube Cancer
    Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Non-Small-Cell Lung Cancer, Lung Cancer, Non-Small Cell
    MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer
    Raleigh Hematology Oncology Association
    Raleigh, North Carolina 27609
    Prostate Cancer
    A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Non-Small-Cell Lung Cancer, Lung Cancer, Non-Small Cell
    Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Raleigh Hematology Oncology Association
    Raleigh, North Carolina 27609
    Non Small Cell Lung Carcinoma
    Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Non-Small-Cell Lung Cancer
    Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Solid Tumor Cancer
    Study Of Ispinesib In Subjects With Breast Cancer
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Breast Cancer
    A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)
    Dermatology and Skin Cancer Center

    Trial Locations
    Dermatology and Skin Cancer Center
    Andrus and Associates Dermatology, P.A.
    Psoriasis
    Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Neoplasms, Breast, Breast Cancer
    Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Human Papillomavirus (HPV) Infection, Cervical Neoplasia
    Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
    Wake Urology
    Raleigh, North Carolina 27607
    Prostate Cancer, Osteoporosis, Fractures
    Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Cancer, Bowel Dysfunction
    Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer Patients
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Carcinoma, Renal Cell, Cancer
    Rollover Study Of Lapatinib In Cancer Patients
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Neoplasms, Breast, Cancer
    Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease
    Site Ref # / Investigator 1911
    Raleigh, North Carolina 27612
    Crohn's Disease
    Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
    Rex Cancer Center at Rex Hospital
    Raleigh, North Carolina 27607
    Prostate Cancer
    Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Multiple Myeloma, Carcinoma, Renal Cell
    Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
    Cancer Centers of North Carolina

    Trial Locations
    Cancer Centers of North Carolina
    Rex Hospital
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase
    Raleigh Neurology Associates, 1540 Sunday Drive
    Raleigh, North Carolina 27607
    Multiple Sclerosis
    Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Neoplasms, Breast, Breast Cancer
    Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Neoplasms, Prostate, Prostate Cancer
    Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Human Papillomavirus Type-16/-18 Infection, Papillomavirus Vaccines, Cervical Neoplasia
    Brain Metastases In ErbB2-Positive Breast Cancer
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Neoplasms, Breast
    Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)
    Cancer Center of North Carolina
    Raleigh, North Carolina 27614
    Prostate Cancer
    Assessment and Tracking of Long-term Alefacept Safety
    Andrus & Associates Dermatology, PA
    Raleigh, North Carolina 27609
    Psoriasis
    Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women
    Test Facility
    Raleigh, North Carolina 27609
    Hypoactive Sexual Desire Disorder
    Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung Cancer
    Duke Raleigh Hospital
    Raleigh, North Carolina 27609
    Non Small Cell Lung Cancer
    Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer
    Duke Raleigh Hospital
    Raleigh, North Carolina 27609
    Carcinoma, Non-Small-Cell Lung
    AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy
    Cancer Centers of North Carolina (Main)
    Raleigh, North Carolina 27607
    Small Cell Lung Cancer
    Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Neoplasms, Breast